Triglycerides and endothelial function in type 2 diabetes

European Journal of Clinical Investigation

Volumn 31, Issue 7, 2001, Pages 560-562

  Rongen, G A ^a   Tack, C J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BEZAFIBRATE; CERIVASTATIN; CIPROFIBRATE; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; TRIACYLGLYCEROL;

CLINICAL TRIAL; ENDOTHELIUM; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; VASODILATATION;

ARTERIOSCLEROSIS; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTRIGLYCERIDEMIA; VASODILATION;

EID: 0034934828     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2001.00854.x     Document Type: Note

References (34)

1. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension
2. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia
3. Effects of long-term cigarette smoking on endothelium-dependent responses in humans
4. Homocysteine and coronary heart disease: A review of the current evidence
5. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease
6. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease
7. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
8. Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: Role of dyslipidaemia
9. Insulin therapy improves endothelial function in type 2 diabetes
10. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus
11. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus
12. Endothelial dysfunction is detectable in young normotensive first- degree relatives of subjects with type 2 diabetes in association with insulin resistance
13. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo
14. Elevated skeletal muscle blood flow in noncomplicated type 1 diabetes mellitus, role of nitric oxide and sympathetic tone
15. Endothelium-dependent vascular relaxation in patients with type 1 diabetes
16. Dissociation between insulin sensitivity of glucose uptake and endothelial function in normal subjects
17. Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease
18. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance
19. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance
20. Gemfibrozil improves insulin sensitivity and flow mediated vasodilatation in type 2 diabetic patients
21. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation
22. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal
23. Effect of a single high-fat meal on endothelial function in healthy subjects
24. Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes
25. Mortality from coronary heart disease in subjects with type 2 diabetes and nondiabetic subjects with and without prior myocardial infarction
26. Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus
27. A comparison between the effects of gemfibrozil and simvastatin on insulin sensitivity in patients with non-insulin-dependent diabetes mellitus and hyperlipoproteinemia
28. Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants
29. Endothelial dysfunction in men with small LDL particles
30. Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
31. Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study
32. Prevention of the angiographic progression of coronary and vein- graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol
33. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
34. Fibrates, dyslipoproteinaemia and cardiovascular disease